We currently have research studies for Crohn's Disease, Ulcerative Colitis, Irritable Bowel Syndrome, Functional Dyspepsia and Hepatitis C. Participation in a research study has many benefits including: the opportunity to explore new and upcoming therapies and top-notch healthcare at no cost to you.
Research studies investigate drugs that may or may not be approved by the United States Food and Drug Administration. Most of our studies involve investigational drugs that will be approved once our studies are successfully completed. The drugs that we investigate have already completed laboratory testing and are now ready to be studied in affected individuals. These studies are also known as Phase III Research Studies. Your physician will assess your eligibility to participate.
You may obtain more information about clinical trials and a few of the trials that we are participating in by visiting the web at:
Generally, patients are required to have a Screening visit. Screening visit procedures can include (but are not limited to): informed consent, lab specimen collection, EKGs, physical examination, medical history review, surgical history review, medication lists and possibly endoscopic procedures.
Other study visits and requirements vary depending on the study. Our studies may last just a few weeks or up to several years. Participation is voluntary and you may discontinue at any time. Should the study medications not help your illness, you can discontinue at any time. Our physicians will continue to provide your medical care. Study medications are provided at no cost to you. Most importantly, your confidentiality will be maintained.
If you are interested, please ask your physician or contact our research coordinator, Sandy Boone or LaShawna Green, at 419-2120, option 5 on the voice mail system. Or you may email us at email@example.com.